doc. RNDr. Jakub Neradil, Ph.D.

Associate professor, Section of Genetics and Molecular Biology

office: bldg. C13/316
Kamenice 753/5
625 00 Brno

Show on the map

phone:	+420 549 49 6003
e‑mail:

social and academic networks:

Basic information

Type

Total number of publications: 78

2020

Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms

PAUKOVČEKOVÁ Silvia ŠKODA Jan NERADIL Jakub MIKULENKOVÁ Erika CHLAPEK Petr ŠTĚRBA Jaroslav RICHARDSON Desi Raymond VESELSKÁ Renata

Article in Periodical

Cancers, year: 2020, volume: 12, edition: 12, DOI
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration

KRCHNIAKOVÁ Mária ŠKODA Jan NERADIL Jakub CHLAPEK Petr VESELSKÁ Renata

Article in Periodical

International Journal of Molecular Sciences, year: 2020, volume: 21, edition: 9, DOI
Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells

ŠKODA Jan NERADIL Jakub STANICZKOVÁ ZAMBO Iva ŇUŇUKOVÁ Alena MACSEK Peter BOŘÁNKOVÁ Karolína DOBROTKOVÁ Viera NĚMEC Pavel ŠTĚRBA Jaroslav VESELSKÁ Renata

Article in Periodical

Cancers, year: 2020, volume: 12, edition: 1, DOI

2019

Epidermal growth factor receptor as a new target in the treatment of giant cell tumor of bone

MAHDAL Michal NERADIL Jakub PAUKOVČEKOVÁ Silvia STANICZKOVÁ ZAMBO Iva PAZOUREK Lukáš TOMÁŠ Tomáš RAPI Jakub

Conference abstract

Year: 2019, type: Conference abstract
Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario

KÝR Michal POLÁŠKOVÁ Kristýna KUTTNEROVÁ Zuzana MERTA Tomáš NERADIL Jakub BERKOVCOVÁ Jitka HORKÝ Ondřej JEŽOVÁ Marta VESELSKÁ Renata KLEMENT Giannoula Lakka VALÍK Dalibor ŠTĚRBA Jaroslav

Article in Periodical

Frontiers in Oncology, year: 2019, volume: 9, edition: JUL 17 2019, DOI
Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology

NERADIL Jakub KÝR Michal POLÁŠKOVÁ Kristýna KŘEN Leoš MACIGOVÁ Petra ŠKODA Jan ŠTĚRBA Jaroslav VESELSKÁ Renata

Article in Periodical

Frontiers in Oncology, year: 2019, volume: 9, edition: SEP 20, DOI

2018

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis

ŠRÁMEK Martin NERADIL Jakub MACIGOVÁ Petra MÚDRY Peter POLÁŠKOVÁ Kristýna SLABÝ Ondřej NOSKOVÁ Hana ŠTĚRBA Jaroslav VESELSKÁ Renata

Article in Periodical

International Journal of Molecular Sciences, year: 2018, volume: 19, edition: 9, DOI
Letter to Editor: FS Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)

ROHLEDER Ondřej MÚDRY Peter NERADIL Jakub NOSKOVÁ Hana SLABÝ Ondřej ŠTĚRBA Jaroslav

Article in Periodical

Bone, year: 2018, volume: 116, edition: NOV, DOI
Molekulární tumor board - personalizovaná medicína v každodenní praxi

POLÁŠKOVÁ Kristýna MARTINČEKOVÁ Alexandra ZAPLETALOVÁ Danica MERTA Tomáš NOSKOVÁ Hana SLABÝ Ondřej NERADIL Jakub VESELSKÁ Renata ŠTĚRBA Jaroslav

Conference abstract

Year: 2018, type: Conference abstract

2017

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene

MÚDRY Peter SLABÝ Ondřej NERADIL Jakub ŠOUKALOVÁ Jana MELICHÁRKOVÁ Kristýna ROHLEDER Ondřej JEŽOVÁ Marta SEEHOFNEROVÁ Anna PONECHAL MICHU Elleni VESELSKÁ Renata ŠTĚRBA Jaroslav

Article in Periodical

BMC Cancer, year: 2017, volume: 17, edition: 119, DOI